Eli Lilly and Co (LLY)
787.02
+23.04
(+3.02%)
USD |
NYSE |
May 15, 16:00
788.15
+1.13
(+0.14%)
After-Hours: 20:00
Eli Lilly Cash from Investing (Quarterly): -1.178B for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.178B |
December 31, 2023 | -2.924B |
September 30, 2023 | -3.080B |
June 30, 2023 | -459.10M |
March 31, 2023 | -688.80M |
December 31, 2022 | -943.50M |
September 30, 2022 | -955.30M |
June 30, 2022 | -826.50M |
March 31, 2022 | -1.038B |
December 31, 2021 | -484.20M |
September 30, 2021 | -616.50M |
June 30, 2021 | -483.30M |
March 31, 2021 | -1.284B |
December 31, 2020 | -674.10M |
September 30, 2020 | -313.50M |
June 30, 2020 | -210.40M |
March 31, 2020 | -1.061B |
December 31, 2019 | -41.40M |
September 30, 2019 | -423.80M |
June 30, 2019 | 61.00M |
March 31, 2019 | -7.679B |
December 31, 2018 | -659.00M |
September 30, 2018 | -398.10M |
June 30, 2018 | 3.133B |
March 31, 2018 | -170.30M |
Date | Value |
---|---|
December 31, 2017 | 1.653B |
September 30, 2017 | -1.758B |
June 30, 2017 | -2.249B |
March 31, 2017 | -1.430B |
December 31, 2016 | -1.178B |
September 30, 2016 | -794.70M |
June 30, 2016 | -1.021B |
March 31, 2016 | -145.40M |
December 31, 2015 | 253.70M |
September 30, 2015 | -570.10M |
June 30, 2015 | 182.40M |
March 31, 2015 | 160.80M |
December 31, 2014 | -2.179B |
September 30, 2014 | -1.650B |
June 30, 2014 | -468.90M |
March 31, 2014 | 388.40M |
December 31, 2013 | -1.232B |
September 30, 2013 | -943.80M |
June 30, 2013 | -1.252B |
March 31, 2013 | 1.355B |
December 31, 2012 | -1.662B |
September 30, 2012 | -132.70M |
June 30, 2012 | -385.30M |
March 31, 2012 | -652.30M |
December 31, 2011 | -1.877B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.080B
Minimum
Sep 2023
61.00M
Maximum
Jun 2019
-881.19M
Average
-681.45M
Median
Cash from Investing (Quarterly) Benchmarks
Amgen Inc | -217.00M |
Biogen Inc | -66.00M |
Johnson & Johnson | -464.00M |
Vertex Pharmaceuticals Inc | -2.136B |
Viking Therapeutics Inc | -459.79M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 1.166B |
Cash from Financing (Quarterly) | -311.30M |
Free Cash Flow | -3.896B |
Free Cash Flow Per Share (Quarterly) | 0.0921 |
Free Cash Flow to Equity (Quarterly) | -902.90M |
Free Cash Flow to Firm (Quarterly) | 201.53M |
Free Cash Flow Yield | -0.55% |